117 related articles for article (PubMed ID: 33614706)
1. A Risk Prediction Model for Breast Cancer Based on Immune Genes Related to Early Growth Response Proteins Family.
Zhou X; Zhang FY; Liu Y; Wei DX
Front Mol Biosci; 2020; 7():616547. PubMed ID: 33614706
[TBL] [Abstract][Full Text] [Related]
2. The Role of Early Growth Response Family Members 1-4 in Prognostic Value of Breast Cancer.
Hao L; Huang F; Yu X; Xu B; Liu Y; Zhang Y; Zhu Y
Front Genet; 2021; 12():680132. PubMed ID: 34178038
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic analyses of early growth response proteins (EGRs) in human breast carcinoma based on database analysis.
Fei Y; Yu H; Huang S; Chen P; Pan L
PeerJ; 2019; 7():e8183. PubMed ID: 31844579
[TBL] [Abstract][Full Text] [Related]
4. An integrated pan-cancer analysis of identifying biomarkers about the EGR family genes in human carcinomas.
Hua Y; Wang H; Ye Z; Zheng D; Zhang X
Comput Biol Med; 2022 Sep; 148():105889. PubMed ID: 35933961
[TBL] [Abstract][Full Text] [Related]
5. The Landscape of Early Growth Response Family Members 1-4 in Hepatocellular Carcinoma: Their Biological Roles and Diagnostic Utility.
Liang J; Wang J; Zeng J; Bai Z; Zheng Z; Zheng Y; Jiang F; Wu D
Dis Markers; 2022; 2022():3144742. PubMed ID: 36046377
[TBL] [Abstract][Full Text] [Related]
6. Involvement of early growth response factors in TNFα-induced aromatase expression in breast adipose.
To SQ; Simpson ER; Knower KC; Clyne CD
Breast Cancer Res Treat; 2013 Feb; 138(1):193-203. PubMed ID: 23338760
[TBL] [Abstract][Full Text] [Related]
7. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study.
Zheng Y; Wu C; Yan H; Chen S
Clin Chim Acta; 2020 Jul; 506():110-121. PubMed ID: 32156604
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer.
Bai J; Zhang X; Xiang ZX; Zhong PY; Xiong B
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1134-1141. PubMed ID: 32096169
[TBL] [Abstract][Full Text] [Related]
10. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
11. Identification of immune-related genes as prognostic factors in bladder cancer.
Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
[TBL] [Abstract][Full Text] [Related]
12. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
13. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
[TBL] [Abstract][Full Text] [Related]
14. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
Wu J; Zhang Y; Li M
J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Six-Immune-Related Long Non-coding RNA Signature for Predicting Survival and Immune Infiltrating Status in Breast Cancer.
Li Z; Li Y; Wang X; Yang Q
Front Genet; 2020; 11():680. PubMed ID: 32733537
[TBL] [Abstract][Full Text] [Related]
16. Tumour-Infiltrating Immune Cell-Based Subtyping and Signature Gene Analysis in Breast Cancer Based on Gene Expression Profiles.
Jiang J; Pan W; Xu Y; Ni C; Xue D; Chen Z; Chen W; Huang J
J Cancer; 2020; 11(6):1568-1583. PubMed ID: 32047563
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
Liang Y; Zhang C; Dai DQ
World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
[No Abstract] [Full Text] [Related]
19. Prognostic nomogram based on immune scores for breast cancer patients.
Wang J; Li Y; Fu W; Zhang Y; Jiang J; Zhang Y; Qi X
Cancer Med; 2019 Sep; 8(11):5214-5222. PubMed ID: 31342666
[TBL] [Abstract][Full Text] [Related]
20. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
